Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.700 USD | +2.66% |
|
+4.65% | -89.31% |
25/06 | Jaguar Health to Seek European Regulatory Approval for Dog Diarrhea Treatment | MT |
11/06 | Jaguar Health Establishes First Site for Canalevia-CA1 Field Study | MT |
Main competitors
Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|
- | - | -0.27x | - | -0.11x | 0.06x | 0.06x | 35.76L | ||
0.75% | 0.83% | 37.3x | 27.34x | 12.31x | 28.09x | 30.22x | 71TCr | ||
3.34% | 3.44% | 15.04x | 5.05x | 4.2x | 11.56x | 12.84x | 38TCr | ||
3.42% | 3.57% | 27.26x | 48.13x | 6.59x | 13.78x | 14.23x | 34TCr | ||
3% | 3.5% | 16.85x | 9.51x | 6.08x | 12.14x | 13.41x | 31TCr | ||
3.84% | 3.94% | 14.15x | 5.39x | 3.48x | 8.6x | 9.87x | 26TCr | ||
3.26% | 3.41% | 17.15x | 5.1x | 4.63x | 11.21x | 12.22x | 24TCr | ||
2.28% | 2.39% | 22.3x | 4.85x | 4.15x | 12.2x | 12.93x | 22TCr | ||
3.86% | 4.05% | 10.68x | 3.77x | 3.46x | 7.48x | 8.34x | 21TCr | ||
3.25% | 3.41% | 22.58x | 18.07x | 5.78x | 11.22x | 13.13x | 16TCr | ||
6.66% | 6.8% | 11.96x | 1.61x | 2.95x | 7.29x | 8.47x | 15TCr | ||
2.96% | 3.1% | 20.14x | 6.09x | 5.15x | 9.43x | 11.35x | 14TCr | ||
-.--% | -.--% | 31.18x | 6.09x | 9.28x | 19.53x | 20.52x | 12TCr | ||
4.91% | 5.14% | 11.69x | 1.29x | 2.42x | 7.94x | 8.67x | 12TCr | ||
5.29% | 5.47% | 10.66x | 4.57x | 2.78x | 7.43x | 7.89x | 9.54TCr | ||
4.61% | 4.9% | 9.9x | 3.85x | 2.2x | 6.5x | 7.46x | 7.69TCr | ||
3.69% | 1.73% | 25.81x | 5.62x | 8.57x | 16.87x | 17.64x | 7.64TCr | ||
0.41% | 0.47% | 49.83x | 6.79x | 11x | 40.26x | 43.95x | 5.3TCr | ||
4.57% | 4.66% | 28.12x | 1.01x | 2.34x | 8.64x | 21.78x | 4.69TCr | ||
Average | 3.34% | 3.38% | 20.12x | 9.12x | 5.12x | 12.64x | 14.47x | 19.4TCr | |
Weighted average by Cap. | 2.93% | 3.04% | 22.35x | 13.96x | 6.32x | 14.74x | 16.20x |
- Stock Market
- Equities
- JAGX Stock
- Sector Jaguar Health, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition